Ezra E W Cohen

Ezra E W Cohen

UNVERIFIED PROFILE

Are you Ezra E W Cohen?   Register this Author

Register author
Ezra E W Cohen

Ezra E W Cohen

Publications by authors named "Ezra E W Cohen"

Are you Ezra E W Cohen?   Register this Author

100Publications

2553Reads

50Profile Views

HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer.

Cancer Res 2020 Feb 17;80(4):732-746. Epub 2019 Dec 17.

Department of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-19-1771DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024675PMC
February 2020

Selection of Head and Neck Cancer Patients for Intensive Therapy.

Int J Radiat Oncol Biol Phys 2020 01 30;106(1):157-166. Epub 2019 Sep 30.

Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California; Center for Precision Radiation Medicine, La Jolla, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2019.09.011DOI Listing
January 2020

p16 status and choice of chemotherapy in the KEYNOTE-040 study - Authors' reply.

Lancet 2019 10;394(10206):1323

The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, National Institute of Health Research Biomedical Research Centre, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(19)31264-4DOI Listing
October 2019

Immune Modulation of Head and Neck Squamous Cell Carcinoma and the Tumor Microenvironment by Conventional Therapeutics.

Clin Cancer Res 2019 07 27;25(14):4211-4223. Epub 2019 Feb 27.

Department of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-0871DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635035PMC
July 2019

A Threshold Model for T-Cell Activation in the Era of Checkpoint Blockade Immunotherapy.

Front Immunol 2019 18;10:491. Epub 2019 Mar 18.

Department of Radiation Medicine and Applied Sciences, San Diego Moores Cancer Center, University of California, San Diego, San Diego, CA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2019.00491DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431643PMC
March 2019

Leveraging TCR Affinity in Adoptive Immunotherapy against Shared Tumor/Self-Antigens.

Cancer Immunol Res 2019 01 27;7(1):40-49. Epub 2018 Nov 27.

Laboratory of Cellular Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, California.

View Article

Download full-text PDF

Source
http://cancerimmunolres.aacrjournals.org/lookup/doi/10.1158/
Publisher Site
http://dx.doi.org/10.1158/2326-6066.CIR-18-0371DOI Listing
January 2019

A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors.

Cancer Chemother Pharmacol 2018 08 9;82(2):309-317. Epub 2018 Jun 9.

Section of Hematology Oncology, Department of Medicine, University of Chicago, 5841 S. Maryland Avenue, MC 2115, Chicago, IL, 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-018-3619-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739841PMC
August 2018

Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience.

Oral Oncol 2018 05 16;80:16-22. Epub 2018 Mar 16.

Department of Radiation and Cellular Oncology, University of Chicago, 5758 S. Maryland Avenue, M/C 9006, Chicago, IL 60637, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2018.03.008DOI Listing
May 2018

Rising incidence of oral tongue cancer among white men and women in the United States, 1973-2012.

Oral Oncol 2017 04 28;67:146-152. Epub 2017 Feb 28.

National Cancer Institute, Division of Cancer Epidemiology and Genetics, Rockville, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2017.02.019DOI Listing
April 2017

Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize.

Nat Commun 2016 10 4;7:13019. Epub 2016 Oct 4.

Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California 92093, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms13019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059467PMC
October 2016

Considering the survivorship care needs of head and neck cancer survivors.

Oral Oncol 2016 06 26;57:61-2. Epub 2016 Apr 26.

Program Manager, National Cancer Survivorship Resource Center, American Cancer Society, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2016.04.012DOI Listing
June 2016

American Cancer Society Head and Neck Cancer Survivorship Care Guideline.

CA Cancer J Clin 2016 05 22;66(3):203-39. Epub 2016 Mar 22.

Director, The George Washington University Cancer Institute, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3322/caac.21343DOI Listing
May 2016

Importance of Radiation Oncologist Experience Among Patients With Head-and-Neck Cancer Treated With Intensity-Modulated Radiation Therapy.

J Clin Oncol 2016 Mar 4;34(7):684-90. Epub 2016 Jan 4.

Isabel J. Boero, Anthony J. Paravati, Ezra E.W. Cohen, Loren K. Mell, and James D. Murphy, University of California San Diego, La Jolla; Quynh-Thu Le, Stanford University, Stanford, CA; and Beibei Xu, Peking University, Beijing, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.9898DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872027PMC
March 2016

Towards a personalized treatment of head and neck cancer.

Am Soc Clin Oncol Educ Book 2015 :28-32

From the Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, CA; Moores Cancer Center, University of California San Diego, La Jolla, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2015.35.28DOI Listing
February 2016

Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo.

Target Oncol 2015 Dec 6;10(4):501-8. Epub 2015 Jan 6.

Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive, La Jolla, CA, 92093, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11523-014-0353-6
Publisher Site
http://dx.doi.org/10.1007/s11523-014-0353-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492891PMC
December 2015

Lenvatinib in Advanced, Radioactive Iodine-Refractory, Differentiated Thyroid Carcinoma.

Clin Cancer Res 2015 Dec 20;21(24):5420-6. Epub 2015 Oct 20.

Solid Tumor Therapeutics Program, UCSD Moores Cancer Center, La Jolla, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-0923DOI Listing
December 2015

DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer.

PLoS One 2014 14;9(7):e102112. Epub 2014 Jul 14.

Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois, United States of America; The University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0102112PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096922PMC
November 2015

Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and Cilengitide.

Clin Cancer Res 2015 Nov 21;21(22):5092-9. Epub 2015 Jul 21.

Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois. Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, Illinois. Comprehensive Cancer Center, The University of Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-15-0427DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677671PMC
November 2015

Integrated genomic analysis suggests MLL3 is a novel candidate susceptibility gene for familial nasopharyngeal carcinoma.

Cancer Epidemiol Biomarkers Prev 2015 Aug 26;24(8):1222-8. Epub 2015 May 26.

Department of Pediatrics, The University of Chicago, Chicago, Illinois. The University of Chicago Comprehensive Cancer Center, The University of Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-15-0275DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526396PMC
August 2015

Mechanisms of and therapeutic approaches for overcoming resistance to epidermal growth factor receptor (EGFR)-targeted therapy in squamous cell carcinoma of the head and neck (SCCHN).

Oral Oncol 2015 May 26;51(5):399-408. Epub 2015 Feb 26.

Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2015.01.018DOI Listing
May 2015

Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck.

Oral Oncol 2015 Apr 17;51(4):291-8. Epub 2014 Dec 17.

Department of Internal Medicine, Division of Hematology-Oncology, University of California, San Diego, La Jolla, CA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2014.11.012DOI Listing
April 2015

Reply to s. Chakraborty et al.

J Clin Oncol 2015 Mar 9;33(8):968. Epub 2015 Feb 9.

University of Chicago, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.59.6189DOI Listing
March 2015

Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes.

Clin Cancer Res 2015 Feb 9;21(4):870-81. Epub 2014 Dec 9.

Department of Medicine, The University of Chicago, Chicago, Illinois. The University of Chicago Comprehensive Cancer Center, Chicago, Illinois. Institute for Genomics and Systems Biology, The University of Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-2481DOI Listing
February 2015

p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitors.

PLoS One 2014 5;9(3):e90171. Epub 2014 Mar 5.

Department of Medicine, University of Chicago, Chicago, Illinois, United States of America; Committee on Cancer Biology, University of Chicago, Chicago, Illinois, United States of America; Comprehensive Cancer Center; University of Chicago, Chicago, Illinois, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0090171PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943907PMC
January 2015

Rare occurrence of EGFRvIII deletion in head and neck squamous cell carcinoma.

Oral Oncol 2015 Jan 23;51(1):53-8. Epub 2014 Sep 23.

Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA; Institute for Genomics and Systems Biology, Chicago, IL, USA; The University of Chicago Comprehensive Cancer Research Center, Chicago, IL, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2014.08.014DOI Listing
January 2015

Pharmacokinetics of single-agent axitinib across multiple solid tumor types.

Cancer Chemother Pharmacol 2014 Dec 22;74(6):1279-89. Epub 2014 Oct 22.

Department of Clinical Pharmacology, Pfizer Inc, San Diego, CA, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00280-014-2606
Web Search
http://link.springer.com/10.1007/s00280-014-2606-6
Publisher Site
http://dx.doi.org/10.1007/s00280-014-2606-6DOI Listing
December 2014

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer.

J Clin Oncol 2014 Sep 21;32(25):2735-43. Epub 2014 Jul 21.

Ezra E.W. Cohen, Theodore G. Karrison, Masha Kocherginsky, Jeffrey Mueller, Robyn Egan, Tanguy Y. Seiwert, Victoria M. Villaflor, Daniel J. Haraf, and Everett E. Vokes, University of Chicago, Chicago; Bruce E. Brockstein, North Shore University Health System, Evanston; Mark B. Agulnik and Bharat B. Mittal, Northwestern University, Chicago, IL; Chao H. Huang, University of Kansas and Veterans Affairs Medical Center, Kansas City, KS; Furhan Yunus and Sandeep Samant, University of Tennessee, Memphis, TN; Luis E. Raez, University of Miami, Miami, FL; Ranee Mehra, Fox Chase Cancer Center, Philadelphia, PA; Priya Kumar and Frank Ondrey, University of Minnesota, Minneapolis, MN; and Patrice Marchand and Bettina Braegas, Nuvisan Oncology, Le Kremlin-Bicêtre, France.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/07/18/JCO.2013.54
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.54.6309
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.54.6309DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876357PMC
September 2014

An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck.

Cancer Chemother Pharmacol 2014 Jun 9;73(6):1227-39. Epub 2014 Apr 9.

Section of Hematology and Oncology, University of Chicago, 5841 South Maryland Avenue, MC 2115, Chicago, IL, 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-014-2459-zDOI Listing
June 2014

Race and competing mortality in advanced head and neck cancer.

Oral Oncol 2014 Jan 14;50(1):40-4. Epub 2013 Oct 14.

Department of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, CA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2013.09.012DOI Listing
January 2014

Study of functional infrared imaging for early detection of mucositis in locally advanced head and neck cancer treated with chemoradiotherapy.

Oral Oncol 2013 Oct 27;49(10):1025-31. Epub 2013 Aug 27.

Department of Medicine, University of Chicago, United States; University of Chicago Comprehensive Cancer Center, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2013.07.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797568PMC
October 2013

Cabozantinib in progressive medullary thyroid cancer.

J Clin Oncol 2013 Oct 3;31(29):3639-46. Epub 2013 Sep 3.

Rossella Elisei, University of Pisa, Pisa; Lisa Licitra, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico-Istituto Nazionale dei Tumori, Milan, Italy; Martin J. Schlumberger, Institut Gustave Roussy, University Paris-Sud, Villejuif, France; Stefan P. Müller, Universitatsklinikum Essen, Essen; Michael C. Kreissl, Universitätsklinikum Würzburg, Würzburg, Germany; Patrick Schöffski, University Hospitals Leuven, Leuven, Belgium; Marcia S. Brose, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA; Manisha H. Shah, Ohio State University Medical Center, Columbus, OH; Barbara Jarzab, Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie Oddział w Gliwicach, Gliwice, Poland; Viktor Medvedev, Medical Radiological Research Centre of the Russian Academy of Medical Sciences, Obninsk, Russia; Bruno Niederle, Medizinische Universität Wien, Wien, Austria; Ezra E.W. Cohen, University of Chicago, Chicago, IL; Lori J. Wirth, Massachusetts General Hospital, Boston, MA; Haythem Ali, Henry Ford Health System, Detroit, MI; Colin Hessel and Yifah Yaron, Exelixis, South San Francisco, CA; Douglas Ball and Barry Nelkin, Johns Hopkins University School of Medicine, Baltimore, MD; and Steven I. Sherman, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.48.4659DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164813PMC
October 2013

Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy.

J Geriatr Oncol 2013 Oct 10;4(4):327-33. Epub 2013 Jun 10.

University of Chicago, Department of Medicine, Section of Hematology/Oncology, Chicago, IL, USA; University of Chicago Comprehensive Cancer Center, Chicago, IL, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18794068130005
Publisher Site
http://dx.doi.org/10.1016/j.jgo.2013.05.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413907PMC
October 2013

Modifiable risk behaviors in patients with head and neck cancer.

Cancer 2013 Jul 10;119(13):2419-26. Epub 2013 Apr 10.

Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27993DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687000PMC
July 2013

Diarrhea associated with afatinib: an oral ErbB family blocker.

Expert Rev Anticancer Ther 2013 Jun 18;13(6):729-36. Epub 2013 Mar 18.

Graduate Institute of Oncology and Cancer Research Center, National Taiwan University Hospital, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/era.13.31
Publisher Site
http://dx.doi.org/10.1586/era.13.31DOI Listing
June 2013

Pharmacoeconomic issues in head and neck oncology.

Curr Opin Oncol 2013 May;25(3):213-7

Section of Hematology/Oncology, The University of Chicago Medicine, Chicago, Illinois 60637-1470, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e32835ff422DOI Listing
May 2013

Multidisciplinary care of the patient with head and neck cancer.

Surg Oncol Clin N Am 2013 Apr 4;22(2):179-215. Epub 2013 Feb 4.

Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL 60637-1470, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soc.2012.12.001DOI Listing
April 2013

Cabozantinib for the treatment of advanced medullary thyroid cancer.

Adv Ther 2012 Nov 25;29(11):925-34. Epub 2012 Oct 25.

Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Chicago, 5841 S. Maryland Ave., Chicago, IL 60645, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12325-012-0060-6
Publisher Site
http://dx.doi.org/10.1007/s12325-012-0060-6DOI Listing
November 2012

Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy.

Oral Oncol 2012 Oct 22;48(10):1025-1030. Epub 2012 May 22.

Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, United States; Comprehensive Cancer Center, University of Chicago, Chicago, IL, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2012.04.004DOI Listing
October 2012

Chemoradiation for patients with large-volume laryngeal cancers.

Head Neck 2012 Aug 3;34(8):1162-7. Epub 2011 Nov 3.

Department of Surgery, Section of Otolaryngology/Head and Neck Surgery, University of Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.21888DOI Listing
August 2012

The role of chemotherapy in locally advanced head and neck squamous cell carcinoma.

Semin Radiat Oncol 2012 Jul;22(3):198-206

SS Giovanni e Paolo Hospital, Medical Oncology Division, Department of Medicine, University of Chicago, Chicago, IL 60637-1470, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semradonc.2012.03.004DOI Listing
July 2012

Novel molecular targeted therapies for refractory thyroid cancer.

Head Neck 2012 May 4;34(5):736-45. Epub 2011 May 4.

Cleveland Clinic Florida, Weston, Florida, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hed.21755
Publisher Site
http://dx.doi.org/10.1002/hed.21755DOI Listing
May 2012

Targeted and cytotoxic therapy in coordinated sequence (TACTICS): erlotinib, bevacizumab, and standard chemotherapy for non-small-cell lung cancer, a phase II trial.

Clin Lung Cancer 2012 Mar 18;13(2):123-8. Epub 2011 Nov 18.

Section of Hematology and Oncology, Department of Medicine, and Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2011.10.001DOI Listing
March 2012

Novel targeted therapies in head and neck cancer.

Expert Opin Investig Drugs 2012 Mar 12;21(3):281-95. Epub 2012 Jan 12.

Medical Oncology Department, Barretos Cancer Hospital, São Paulo, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2012.651455DOI Listing
March 2012

Airway management before chemoradiation for advanced head and neck cancer.

Head Neck 2012 Feb 7;34(2):254-9. Epub 2011 Mar 7.

Department of Surgery, Section of Otolaryngology-Head and Neck Surgery, University of Chicago Medical Center, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.21729DOI Listing
February 2012

Single sample expression-anchored mechanisms predict survival in head and neck cancer.

PLoS Comput Biol 2012 Jan 26;8(1):e1002350. Epub 2012 Jan 26.

Center for Biomedical Informatics, The University of Chicago, Chicago, Illinois, United States of America.

View Article

Download full-text PDF

Source
http://dx.plos.org/10.1371/journal.pcbi.1002350
Publisher Site
http://dx.doi.org/10.1371/journal.pcbi.1002350DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266878PMC
January 2012

The effect of thalidomide on the pharmacokinetics of irinotecan and metabolites in advanced solid tumor patients.

Cancer Chemother Pharmacol 2011 Dec 23;68(6):1629-32. Epub 2011 Aug 23.

Department of Medicine, Section of Hematology/Oncology, University of Chicago, 5841 S Maryland Avenue, MC2115, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-011-1727-4
Publisher Site
http://dx.doi.org/10.1007/s00280-011-1727-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259680PMC
December 2011

Diastolic blood pressure as a biomarker of axitinib efficacy in solid tumors.

Clin Cancer Res 2011 Jun 29;17(11):3841-9. Epub 2011 Apr 29.

Cleveland Clinic Taussig Cancer Institute, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-2806DOI Listing
June 2011

The next phase of chemoprevention research.

Cancer Prev Res (Phila) 2011 Mar;4(3):293-5

Section of Hematology/Oncology, Department of Medicine, University of Chicago MC2115, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-11-0012DOI Listing
March 2011

Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer.

Radiother Oncol 2010 Nov 9;97(2):318-21. Epub 2010 Oct 9.

Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2010.09.003DOI Listing
November 2010